Skip to main content


Fig. 2 | Molecular Cancer

Fig. 2

From: Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression

Fig. 2

The circAKT3 expression level is correlated with poor prognosis in GC patients receiving CDDP therapy. a Expression levels of circAKT3 in tissue samples of 105 GC patients (CDDP-resistant and CDDP-sensitive groups) normalized to GAPDH expression. b Kaplan-Meier survival curves of DFS for patients with high (n = 53) or low (n = 52) circAKT3 expression. The median circAKT3 expression value was used as the cutoff. c ROC curves of circAKT3. d Multivariate analyses of hazard ratios for DFS. The results are presented as the mean ± SEM

Back to article page